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Lipid synthesis and accumulation represent a major step
in sebocyte di¡erentiation and it may be of importance
for sebocytes to express two families of transcription
factors, CCAAT/enhancer binding proteins (c/EBPs)
and peroxisome proliferator-activated receptors (PPARs),
which were found to play a crucial role in the di¡eren-
tiation of adipocytes. Using the immortalized human
sebaceous gland cell line SZ95 we examined the expres-
sion of the molecules before and after treatment with
testosterone, 5a-dihydrotestosterone, dexamethasone,
17b-estradiol and genistein, at 6, 12, 24, and 48 h, respec-
tively. Reverse transcription-PCR analysis showed
expression of peroxisome proliferator-activated recep-
tors -a, d, c1, -c2 and CCAAT/enhancer binding
proteins-a, b, c d in native SZ95 sebocytes. In wes-
tern blot studies, high levels of CCAAT/enhancer bind-
ing proteins-a and -b, and peroxisome proliferator-
activated receptors-c were expressed at 6, 24, and 12 h,
respectively. Immunostaining of the cultured sebocytes
showed the CCAAT/enhancer binding proteins-a and -b
mainly localized within nuclei, whereas peroxisome
proliferator-activated receptors-c in the cytoplasm.
Strong staining of sebocytes was immunohistochemi-
cally revealed in the basal layer of sebaceous glands in
human scalp and sebaceous nevus. Genistein down-
regulated the expression of CCAAT/enhancer binding
proteins-a and -b, and peroxisome proliferator-acti-
vated receptors-c on the protein level. Treatment with
linoleic acid for 48 h induced further di¡erentiation of
sebocytes leading to abundant lipid synthesis. Key words:
androgens/genistein/sebaceous glands/steroids/transcription fac-
tors. J Invest Dermatol 121:441 ^447, 2003
S
ebaceous lipogenesis, leading to accumulation of lipid
droplets and ¢nally to sebum excretion, represents a ma-
jor step of the di¡erentiation process in sebaceous gland
cells (Downie and Kealey, 1998). Excessive sebum pro-
duction is supposed to be of crucial importance in the
pathogenesis of acne (Kligman, 1974). Over the past decade, con-
siderable progress has been made in our understanding of the
molecular events regulating adipocyte di¡erentiation. Several
transcription factors have been identi¢ed, which act cooperatively
and sequentially to trigger the terminal di¡erentiation program
in cultured pre-adipocyte cell lines, such as the NIH 3T3 ¢bro-
blast cell line (MacDougald and Lane, 1995; Mandrup and Lane,
1997). Among them, CCAAT/enhancer binding proteins (c/EBP)
and peroxisome proliferator-activated receptors (PPAR) are
thought to play crucial parts. Whereas high levels of c/EBP-b
and c/EBP-d are expressed in the early induction phase, c/EBP-a
maintains terminal adipocyte di¡erentiation (Mandrup and Lane,
1997). Expression of c/EBP-g is ubiquitous and constitutive and
the murine c/EBP-g was shown to act as a transdominant nega-
tive regulator on the transcriptional ability of c/EBP-b and
c/EBP-a (Cooper et al, 1995).
Subtypes of human PPAR, including PPAR-a, PPAR-d, and
PPAR-g, share a high degree of amino acid sequence as well as
functional similarities and can bind to retinoid X receptor a to
form heterodimers (MacDougald and Lane, 1995). Among PPAR,
PPAR-g was found to be the most adipogenic, followed by
PPAR-a, whereas PPAR-d was rather inactive (Brun et al, 1996).
Alternative splicing of one gene product yields two transcripts of
PPAR-g; whereas PPAR-g1was found to predominate in adipose
tissue and large intestine, PPAR-g2 seemed to play a minor part
even in adipose tissue (Auboeuf et al, 1997). The ratio of PPAR-
g2/-g1 in adipose tissue, however, was found to be correlating
with the extent of human obesity (Vidal-Puig et al, 1997).
PPAR-d expression was found to be activated early in the di¡er-
entiation and its levels remained relatively constant during the
di¡erentiation process (Mandrup and Lane, 1997).
c/EBP and PPAR interact closely to conduct terminal di¡eren-
tiation of adipocytes. c/EBP-d may, by synergizing with c/EBP-
b, enhance the level of PPAR-g expression (Wu et al, 1996). c/
EBP-b is believed to be a transactivator of the c/EBP-a gene and
equally activates the PPAR-g expression. c/EBP-a, whose expres-
sion coincides with the later stages of di¡erentiation, cooperates
with PPAR-g in inducing additional target genes and sustains a
high level of PPAR-g in the mature adipocyte as part of a feed-
forward loop (Fajas et al, 1998).
Speci¢c activators of PPAR have been identi¢ed and tested for
their e¡ect on the adipocyte di¡erentiation (Hihi et al, 2002).
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Strong PPAR-a ligands include the physiologically existent leuko-
triene B4 and synthetic hypolipemic compounds of ¢brates
(e.g.,WY-14643, clo¢brate, feno¢brate). Linoleic acid (LIN) is a
natural PPAR-d/b ligand. 15-deoxy-d(12,14)-prostaglandin J2 is a
natural PPAR-g ligand, as are also the synthetic insulin sensiti-
zing compounds thiazolidinediones (ciglitazone, pioglitazone,
rosiglitazone).
Phytestrogens, such as the soya iso£avones genistein and daid-
zein, are associated with a reduced risk of many hormone-depen-
dent tumors, such as prostate and breast cancer (Barnes et al,
2000). The e¡ect of iso£avones on androgen-dependent derma-
toses, however, remains to be determined.
In this study we examined and compared the expression of
these adipogenesis-related genes in human sebocytes, in order to
understand better the molecular control of human sebocyte dif-
ferentiation and sebum production. The experiments were aimed
to study: (1) the sequential expression of c/EBP (c/EBP-a, -b, -d,
-g) and PPAR (PPAR-g1, -g2, -a, -d); (2) the regulatory e¡ects of
testosterone, 5a-dihydrotestosterone (DHT), dexamethasone,
17b-estradiol (E2), and genistein; and (3) the e¡ect of di¡erent
PPAR agonists on lipogenesis in sebocytes.
MATERIALS AND METHODS
Cell culture and treatment The immortalized sebaceous gland cell
(sebocyte) line SZ95 was used (Zouboulis et al, 1999). The cells were
initially grown in Sebomed basal medium (Biochrom, Berlin, Germany)
containing 10% heat inactivated fetal bovine serum, and 5 ng human
recombinant epidermal growth factor per mL. Before treatment, the
culture medium was switched to serum-free, phenol red-free Sebomed
ready-to-use medium (Biochrom) containing 50 mg bovine pituitary
extract per mL, 5 ng human recombinant epidermal growth factor per
mL, 1 mg fatty acid-free bovine serum albumin per mL, and 0.042 mg
LIN per mL (about 1.510^7 M).1 The cells were treated with
testosterone, DHT, dexamethasone, E2, and genistein at 10^6 M for 0, 6,
12, 24, and 48 h, respectively; 10^6 M WY-14643 and ciglitazone (both
from AG Scienti¢c, San Diego, California) and 10^4 M LIN (Sigma-
Aldrich, Deisenhofen, Germany), speci¢c ligands for PPAR-a, -g, and -d/
b , respectively, were also administered to the cells in serum-free medium
for 48 h to evaluate their e¡ects on lipid synthesis of cultured sebocytes
(Rosen¢eld et al, 1998).
Reverse transcription^polymerase chain reaction (reverse trans-
cription^PCR) studies Total RNA was extracted using a commercial
kit (StrataPrep, Stratagene, La Jolla, California), including a speci¢c DNA
removal step with DNAse. Two micrograms of total RNA was reverse
transcribed using oligo(dT) primers and AMV reverse transcriptase
(Promega, Madison, Wisconsin). The oligonucleotide primers used for
reverse transcription^PCR, synthesized by Gibco-BRL (Tokyo, Japan) are
listed in Table I. PCR ampli¢cation of the complementary DNA was
carried out for 35 consecutive cycles in 50 mL of ampli¢cation bu¡er
(Promega) containing 2.5 U per reaction Tag polymerase (Promega), and
50 and 30 primers each in concentration of 0.5 mM. The thermal pro¢le
began with one cycle 941C for 5 min, and 35 consecutive cycles at 941C
for 30 s, at indicated hybridization temperature (see Table I) for 45 s, at
721C for 45 s and ¢nally at 721C for 10 min in a programmable thermal
controller (GeneAmp, PCR system 2400, Applied Biosystems, Foster
City, California).
Western blot analysis Protein extraction was performed using M-PER
mammalian protein extraction reagent (Pierce, Rockford, Illinois).
Aliquots (10 mg) of total protein isolated from the cultured cells were
heated for 15 min at 951C in a bu¡er to denaturize proteases. Sodium
dodecyl sulfate/polyacrylamide gel electrophoresis of each sample was
performed on 12.5% gels. Proteins were transferred on to a PVDF transfer
membrane (PolyScreen, NEN, Boston, Massachusetts), using a semi-dry
blotting system (Bio-Rad, Hercules, California). The blots were primarily
probed with goat polyclonal IgG (anti-human PPAR-g) and rabbit
polyclonal IgG (anti-human c/EBP-a and -b) (all from Santa Cruz, Santa
Cruz, California) at a concentration of 1:500, respectively, and visualized
using a chromophore-conjugated anti-IgG antibody (1:5000) and enhan-
ced chemiluminescence reagents (ECLWestern blotting luminol reagents,
Santa Cruz) followed by exposure to BioMax light ¢lm (Kodak,
Rochester, New York). The results were analyzed by densitometry (Bio-
1D Version 99,Vilber Lourmat, France).
In vivo and in vitro immunochemical studies Frozen sections (6 mm
thick) of skin specimens taken from occipital scalp of a 34 y old male and
from sebaceous nevus of a 10 y old boy during surgical excision were ¢xed
for 15 min in cold acetone, followed by treatment in 0.3% (vol/vol) H2O2
in methanol for 15 min to block endogenous peroxidase activity, and then
incubation with 0.1% bovine serum albumin for 30 min to block
nonspeci¢c staining. The SZ95 sebocytes were cultured in eight-well
tissue culture chambers (Nunc, Naperville, Illinois) until 50% con£uence,
washed with PBS twice, and then ¢xed and treated in the same way.
Incubations with the aforementioned primary antibodies diluted to 1:250
and 1:1000 in antibody diluent (DAKO, Glostrup, Denmark) for cultured
Table I. Primers used for reverse transcription^PCR analysis of transcription factors PPAR and c/EBP
in cultured transformed human sebocytes





b-actin Sense AGC GGG AAATCG TGC GTG 58 309
Anti-sense CAG GGTACATGG TGG TGG TGC C
PPAR-g1 Sense TCT CTC CGTAAT GGA AGACC 55 474
Anti-sense GCATTATGA GAC ATC CCC AC
PPAR-g2 Sense GCG ATT CCT TCACTG ATA C 58 580
Anti-sense GCATTATGA GAC ATC CCC AC
PPAR-a Sense TCATCA AGA AGACGG AGT CG 55 211
Anti-sense CGG TTA CCTACA GCT CAG AC
PPAR-d Sense TCC CTC TTT CTC AGT TCC TC 58 287
Anti-sense CAG GAG ACA GAA GTG AGG AC
c/EBP-a Sense GAA CAC GAA GCACGATCA G 55 268
Anti-sense CCA AAA CCA AAA GGA AAG GGA G
c/EBP-b Sense TGATAA ACT CTC TGC TCT CCC 55 191
Anti-sense AAA CAT CAACAG CAACAA GCC
c/EBP-g Sense ACC CTG CTC TCATTT CTA CC 55 103
Anti-sense ACA CTA ATT CCG TTC ACC CC
c/EBP-d Sense AAC GAC CCATAC CTC AGAC 55 240
Anti-sense ACA AAT GTA CCT TAG CTG CAT C
1Seltmann H, Hornemann S, Orfanos CE, Zouboulis ChC: Linoleic
acid induces accumulation of neutral lipids in undi¡erentiated human
sebocytes and reduces spontaneous IL-8 secretion. Arch Dermatol Res
291:181, 1999 (Abstr.)
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cells and for tissues, respectively, were carried out at room temperature for
1 h, followed by sequential 10 min incubations with the respective
biotinylated link antibodies and peroxidase-labeled streptavidin (DAKO).
Staining was completed after incubation with diaminobenzidine/
chromogen solution (DAKO) and mounted in aqueous mounting
medium.
Cell proliferation The cultured SZ95 sebocytes were seeded in 96-well
culture plates (Nunc, Naperville, Illinois) at cell densities of 10,000 cells per
well and the sebocyte proliferation before and after treatment was
measured by a colorimetric assay (tetrazolium salt WST-1 based) (Roche,
Mannheim, Germany) and the £uorescence was read on an Emas
precision microplate reader (Molecular Devices, Sunnyvale, California)
with absorbance at 590 nm.
Nile red staining and £ow cytometry SZ95 sebocytes maintained in
Sebomed basal medium supplemented with 10% heat inactivated fetal
bovine serum, 5 ng human recombinant epidermal growth factor per mL,
1 mM CaCl2, and 50 mg gentamycin per mLwere grown over six passages
with and without testosterone (10^11 M, 10^9 M, 10^7 M, 10^5 M). At sub-
con£uence, the sebocytes were subcultured and the medium was
changed every 2 d with fresh supplemented testosterone concentrations.
Adherent SZ95 sebocytes of subcon£uent cultures were detached from
£asks with Accutase (PAA, C˛lbe, Germany), resuspended in complete
medium and centrifuged at 250 g for 10 min. Viable cells were then
resuspended in PBS and stained with Nile red, a £uorescent lipophilic dye
(Sigma). The Nile red stock solution (1mg per mL in acetone) was diluted
in PBS, then added immediately to the cell suspension to achieve a ¢nal
concentration of 1 mg Nile red per ml. To assess the lipid content by £ow
£uorometry, 10,000 cells per sample were analyzed using a FACScalibur
(Becton Dickinson, Plymouth, U.K.) equipped with a 15 mW argon-ion
laser device operated at 488 nm. A short-pass beam splitter transmitted
emission less than 560 nm. Nile red £uorescence was collected through a
530730 nm and 585721 nm band-pass ¢lter, respectively.
Statistical analysis Growth studies were assessed in sixplicate wells of
96 well plates. All other experiments were performed in triplicate dishes.
Statistical signi¢cance of the data was evaluated by the two-sided
Student’s t test. Mean di¡erences were considered to be signi¢cant when
po0.05.
RESULTS
mRNA and protein expression of PPAR-a, -d, -c1, and -c2
and c/EBP-a, -b, -c, and -d in SZ95 sebocytes Reverse
transcription^PCR analysis showed presence of PPAR-a, -d,
-g1, and -g2, and c/EBP-a, -b, -g, and -d in SZ95 sebocytes
(Fig 1). No dynamic alteration could be observed in the native
cells during the time course of culture from 6 to 48 h.
Treatment with various steroid hormones (testosterone, DHT,
E2, dexamethasone) and genistein for up to 48 h seemed to
exert little regulatory e¡ect on the mRNA expression of the
molecules under examination. In western blot studies, high
levels of c/EBP-a, PPAR-g, and c/EBP-b were observed at 6, 12,
and 24 h, respectively (Fig 2). The expression of PPAR-g,
reaching its peak at 12 h, was generally weaker than that of
c/EBP-a and -b. Immunocytochemistry detected the presence of
c/EBP-a and c/EBP-b within nuclei of cultured sebocytes,
whereas PPAR-g was seen mainly in the cytoplasm (Fig 2).
Immunohistochemistry showed strong in vivo expression of
c/EBP-a and c/EBP-b in the sebocytes, especially those in the
basal layer of sebaceous glands (Fig 3). Immunostaining appea-
red to be stronger in sebocytes from sebaceous nevus than those
from occipital scalp. Low levels of PPAR-g were detected.
Among the hormones tested, genistein downregulated the
expression of the three molecules under examination at di¡erent
time points, with maximal rates of ^33% for c/EBP-a at 48 h,
^64% for c/EBP-b at 24 h, and merely ^18% for PPAR-g at
24 h (Fig 4). Table II summarized the densitometrical data of
western blot analysis.
E¡ects of hormones and PPAR agonists on SZ95 sebocytes
There was no regulatory e¡ect of testosterone, DHT,
dexamethasone, E2, and genistein at a concentration of 10^6 M
on SZ95 sebocyte proliferation and no long-term e¡ect of
testosterone on lipid synthesis of SZ95 sebocytes (Fig 5A).
Sebocytes cultured in serum-free medium seemed to produce
more lipids than cultured in serum-containing medium (Fig
5B).Whereas both WY-14643 and ciglitazone at 10^6 M showed
no regulatory e¡ect on cultured sebocytes, treatment with 10^4
M LIN for 48 h signi¢cantly induced lipid accumulation in
SZ95 sebocytes (Fig 5C) and enlarged lipid droplets (Fig 5D),
which was also morphologically re£ected in Fig 6,
where increased cell size was also observed after LIN treatment
(Fig 6B).
DISCUSSION
Cutaneous expressions of c/EBP-a, c/EBP-b, and c/EBP-d have
been demonstrated in normal mouse epidermis (Oh and Smart,
Figure1. Reverse transcription^PCR study of the mRNA expres-
sion of c/EBP-a, -b, -c, and -d (A), and PPAR-a, -d, -c1, and -c2
(B) in cultured human SZ95 sebocytes. Expression of all molecules in-
vestigated was detected, and no marked regulatory e¡ect of testosterone
(T), 5a-dihydrotestosterone (DHT), dexamethasone (DEX), 17b-estradiol
(E2), and genistein (G) was found at 10^6 M for up to 48 h, as compared
with untreated cells group (C).
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1999). Whereas PPAR-d mRNA was shown to be expressed in
both rat preputial gland cells and epidermal cells, PPAR-g1
mRNA was demonstrated only in rat preputial glands (Rosen-
¢eld et al, 1999). Recent studies using PPAR-a, -b, and -g mutant
mice species demonstrated that PPAR-a and -b are important for
the rapid epithelialization of wounded skin; whereas PPAR-a is
mainly involved in the early in£ammatory phase of healing,
PPAR-b is implicated in the control of keratinocyte proliferation
(Michalik et al, 2001). The PPAR-b mutant primary keratinocytes
showed impaired adhesion and migration properties (Michalik
et al, 2001). Activated PPAR-b/-d regulates the expression of genes
associated with apoptosis resulting in an increased resistance of
cultured keratinocytes to cell death (Tan et al, 2001).
As for human skin, expression of c/EBP-a, -b, and -d, espe-
cially high levels of c/EBP-b, have been observed in hair follicles
and sebaceous glands (Maytin and Habener, 1998; Bull et al, 2002).
c/EBP-a was concentrated in the upper epidermis in a predomi-
nantly cytoplasmic location within cells, whereas the highest level
of c/EBP-b was seen in the mid-epidermis, mainly within nuclei
(Maytin and Habener, 1998). PPAR-a, -d, and -g were also de-
tected immunohistochemically in both dermal and epithelial cells
of the human hair follicle (Billoni et al, 2000). In cultured human
keratinocytes and in reconstructed epidermis alike, the gene ex-
pression of PPAR-a and -g has been shown to increase during
keratinocyte di¡erentiation, whereas that of PPAR-d was not
modi¢ed (Rivier et al, 1998). Our in vitro as well as in vivo studies
showed the immunostaining of c/EBP-a and -b mainly in
the nuclei, whereas PPAR-g was expressed in the cytoplasm of se-
bocytes (Figs 2 and 3). The much higher levels of c/EBP-a and -b
in the basal layer of sebaceous glands, especially in the nevus cells
(sebaceous nevus) as compared with the sebocytes from normal
adult sebaceous glands imply their importance in the early di¡er-
entiation of sebocytes (Fig 3). Our reverse transcription^PCR stu-
dies showed consistent mRNA expression of PPAR-a, -d, -g1,
-g2, and c/EBP-a, -b, -g, and -d in cultured sebocytes. The de-
monstration of PPAR-g2, in addition to PPAR-g1, in human
Figure 2.Western blot and immunocytochem-
ical studies of protein expression. The smaller,
less di¡erentiated sebocytes were more strongly
stained for c/EBP-a than the larger well di¡eren-
tiated cells (left below), whereas c/EBP-a was loca-
lized in cell nucleus. High levels of c/EBP-a were
already detected in the early stage of cell growth at
6 h, then decreased and persisted from 12 h to 48 h
at lower levels (left above). c/EBP-b was also loca-
lized intranuclearly (middle below), beginning to be
expressed at 6 h and presenting a crescendo regula-
tion to peak at 48 h (middle above). PPAR-g was seen
mainly in the cytoplasm (right below) and its expres-
sion was generally weaker than that of c/EBP-a and
c/EBP-b, reaching its highest levels at 12 h (right
above).
Figure 3. Immunohistochemical staining for c/EBP-a, c/EBP-b,
and PPAR-c in adult scalp (upper panel) and sebaceous nevus (lower
panel). Strong expression was mainly seen in the basal layer of sebaceous
glands. Nevus cells were more intensely stained than normal sebocytes. c/
EBP-a and c/EBP-b had stronger in vivo expression than PPAR-g at the
same antibody dilution (1:1000).
Figure 4. Regulation of c/EBP-b expression by genistein. Genistein
downregulated the expression of c/EBP-b at 24 h and c/EBP-b at 48 h.
The results are presented as percentages of genistein expression standar-
dized to b-actin in comparison with control.
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sebocytes implicates its signi¢cance in sebocyte di¡erentiation
(Rosen¢eld et al, 1999). The biologic role of c/EBP-g expression in
human sebocytes remains unknown. In western blot analysis, high
levels of c/EBP-a and PPAR-g appeared in the early stage of cell
growth, whereas c/EBP-b expression turned out to be stronger in
a later stage. This ¢nding seems to imply, at least partially, a di¡er-
ent di¡erentiation program in sebocytes as compared with adipo-
cytes, where high levels of c/EBP-b are expressed in the early phase
and c/EBP-a maintains the terminally di¡erentiated state (Man-
drup and Lane, 1997). A possible explanation for this discrepancy
may be related to the di¡erent ¢nal destination of sebocyte versus
adipocyte lipids, whereas in the former lipids are excreted from the
cells and in the latter fat will be stored intracellularly. Better quan-
titative methods, e.g., real-time reverse transcription^PCR techni-
que, are needed to corroborate our observation and to ¢nd if there
also exists a dynamic expression of the examined molecules at the
transcriptional level.
Growth and maturation of sebocytes are known to be pro-
foundly in£uenced by various steroids, especially testosterone
and its metabolite 5-DHT. Our experiments could identify low
levels of regulatory e¡ects of sex steroid hormones on the prolif-
eration and lipid synthesis of cultured SZ95 sebocytes. As shown
in previous work, androgens are only able to stimulate prolifera-
tion of normal and SZ95 sebocytes when the cells are grown in
nutritionally de¢cient culture conditions that partially or totally
inhibit steady-state sebocyte proliferation (Akamatsu et al, 1992;
Zouboulis et al, 1999). Interestingly, androgens, applied as single
agents in vitro, seem to in£uence mainly proliferation but not
lipid synthesis in SZ95 sebocytes, in short- and long-term experi-
ments, and that of rat preputial gland cells (Rosen¢eld
et al, 1998; and this study).This is also evidenced by the observation
that sebocytes cultured in serum-free medium (Sebomed ready-
to-use medium) produce slightly more lipids than those cultured
in 10% fetal bovine serum-containing medium (Fig 5B).
The low level of LIN (10^7 M) in the former medium may also
induce lipid production. These data indicate that the pronounced
regulation of androgens on sebaceous gland physiology in vivo
may need cofactor(s) to become apparent.
In accordance with previous studies on rat preputial gland cells
as well as on human sebocytes1 (Rosen¢eld et al, 1998, 1999; Selt-
mann et al, 1999), we showed the strong stimulatory e¡ect of LIN
on lipid production (Fig 5C,D), indicating the role of PPAR-d in
Figure 5. Flow cytometry of SZ95 sebocytes labeled with Nile red. The entire group of cultured SZ95 sebocytes was identi¢ed to contain lipid
droplets. (A) Testosterone did not modify lipid content of viable SZ95 sebocytes in a long-term experiment (six passages) at any concentration tested (right
curves: control, testosterone 10^11 M, 10^9 M, 10^7 M, and 10^5 M). (B) Sebocytes cultured in serum-containing medium produced slightly less lipids than
those in serum-free medium. (C) Treatment with 10^4 M linoleic acid induces di¡erentiation of cultured sebocytes, leading to higher rates of lipid produc-
tion and (D) larger lipid droplets. FL-1 (500^560 nm) measures mainly the neutral lipids, whereas FL-2 (564^627 nm) measures additionally also the
phospholipids. SSC is related to the internal granularity or complexity of a particle, which represents the lipid droplets in the present experiment.
Figure 6. Nile red staining performed on the SZ95 sebocytes cul-
tured in chamber slides, before (A) and after treatment with 10^4
M linoleic acid for 48 h (B). Note the increased cell size and the accu-
mulating bigger lipid droplets in the cytoplasma (B).
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the terminal di¡erentiation of sebocytes. Moreover, the treated
cell population seemed to increase in their cell size (Fig 6). On
the other hand, the lipid-inducing e¡ect of speci¢c ligands for
PPAR-a and -g in cultured rat preputial gland cells, respectively,
was not observed in human sebocytes (Fig 5C,D). In addition to
a species-speci¢c di¡erence, it is possible that the regulatory e¡ect
of di¡erent ligands (BRL-49653 used in rat preputial sebocytes
versus ciglitazone used in human sebocytes) also varies for certain
PPAR receptors (e.g., PPAR-g).
Although clinicians are familiar with the occurrence of steroid
acne as a long-term steroid e¡ect but also with the bene¢cial
short-term e¡ect of corticosteroids in severe in£ammatory acne,
the exact e¡ect of glucocorticoids on growth and di¡erentiation
of sebaceous glands has not been clearly de¢ned. In this study,
treatment of SZ95 sebocytes with 10^6 M dexamethasone for up
to 48 h did not in£uence cell growth, whereas in previous work
hydrocortisone induced a concentration-dependent increase of se-
bocyte proliferation cultured in a serum-free medium for 7 d
(Zouboulis et al, 1998). In another, yet unpublished study, potent
glucocorticoids seem to decrease signi¢cantly the formation of
lipids within SZ95 sebocytes in a 7 d culture system.
Genistein has been shown to exert anti-lipogenic action and to
augment basal lipolysis in isolated rat adipocytes (Szkudelska et al,
2000). Besides that, genistein inhibited proliferation of precon£u-
ent pre-adipocytes in a time- and concentration-dependent man-
ner (Harmon and Harp, 2001).When added to 2 d postcon£uent
pre-adipocytes during the induction of di¡erentiation, genistein
inhibited mitotic clonal expansion, triglyceride accumulation,
and PPAR-g expression. In this study, genistein at 10^6 M exerted
a downregulatory e¡ect on the expression of c/EBP-a, c/EBP-b,
and PPAR-g at the protein level, whereas it did not a¡ect sebo-
cyte proliferation. Further studies are needed to evaluate the
detected regulatory e¡ect on sebocyte di¡erentiation under
long-term culture condition. Should genistein be further shown
to be able to antagonize the stimulatory e¡ect of LIN on lipid
production in cultured sebocytes, this may indicate that the
decreased intake of many genistein-rich phytestrogen-containing
nutrition products (e.g., soybeans) might be related to the
increased prevalence and severity of acne over the past decades
in Taiwan (personal observation byW. Chen,Taiwan).
In conclusion, the major transcriptional factors c/EBP and
PPARwere demonstrated in cultured human sebocytes. The dy-
namics of their expression seemed to vary from that observed in
adipocytes. In a short-term culture system for up to 48 h, genis-
tein inhibited mainly c/EBP-b and c/EBP-a expression. In con-
trast to adipocytes, PPAR-d seems to play an important part in
the terminal di¡erentiation of sebocytes. Experiments on long-
term culture systems of human sebocytes may add valuable infor-
mation. To observe better the treatment response of the cultured
cells, the use of charcoal-stripped medium may be an alternative
way to eliminate the confounding e¡ect caused by the serum-
containing steroid hormones. Better understanding of the mole-
cular control of sebocyte di¡erentiation and sebum production
may lead to advanced pharmacologic development of more
potent agents for e¡ective treatment of acne.
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